Clinical Trials Directory

Trials / Completed

CompletedNCT05836051

Testing the Effect of ENDS Flavors on Neurotransmission

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The overarching goal of this translational proposal is to determine if neuroactive flavor chemicals can enhance the addiction potential of electronic nicotine delivery systems (ENDS) by altering brain function and behavior.

Detailed description

For this randomized double-blind controlled trial, tobacco users will be randomized to use ENDS with an e-liquid containing a neuroactive flavor (hexyl acetate) vs. an inactive flavor (ethyl acetate) for ten days as a supplement to their typical tobacco use. Laboratory measures of ENDS reinforcement, subjective ENDS ratings, and brain reactivity to the flavor using functional magnetic resonance imaging (fMRI) will be collected at baseline and after ten days of ENDS use.

Conditions

Interventions

TypeNameDescription
OTHERFlavorE-liquid flavor chemicals

Timeline

Start date
2023-06-01
Primary completion
2025-05-30
Completion
2025-07-31
First posted
2023-05-01
Last updated
2025-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05836051. Inclusion in this directory is not an endorsement.